Study of a Smartphone-Based Alcohol Reduction Program

NCT ID: NCT06401967

Last Updated: 2024-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-30

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, open label, single center clinical study enrolling up to 100 adult participants to evaluate the feasibility, acceptability, and preliminary outcomes of the Pivot Clear smartphone-based alcohol reduction program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, open label, single center clinical study conducted with institutional review board (IRB) approval enrolling up to 100 adult participants who report at-risk alcohol consumption behavior and would like to reduce or eliminate alcohol consumption. The study will be performed remotely on an ambulatory basis. Participants will be asked to set up and use the Pivot Clear program. The program includes an app, personal breathalyzer, and short message service (SMS) text-based coaching with an alcohol reduction specialist. The study duration is 52 weeks. While participants will have access to the program for 52 weeks, it is expected that for most participants, most active participation in the program will be complete by 12 weeks. The primary reporting time point will be 12 weeks, with expected passive, longer-term follow-up outcomes collected at 26 weeks and 52 weeks. Participants will receive online questionnaires at intervals throughout the study (baseline, weekly for the first 12 weeks, at 26 weeks and at 52 weeks).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use, Unspecified

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pivot Clear

A program for alcohol reduction

Group Type EXPERIMENTAL

Pivot Clear

Intervention Type BEHAVIORAL

A mobile app and program for alcohol reduction.

BACtrack breathalyzer

Intervention Type DEVICE

Personal breathalyzer device that measures blood alcohol content.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pivot Clear

A mobile app and program for alcohol reduction.

Intervention Type BEHAVIORAL

BACtrack breathalyzer

Personal breathalyzer device that measures blood alcohol content.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Score of ≥ 3 for women and ≥ 4 for men on the AUDIT-C at screening
* Would like to reduce or eliminate alcohol consumption
* Resident of the United States
* Able to read and comprehend English
* Owns and uses a smartphone compatible with the study app (iPhone 6 and above, operating system iOS (iPhone operating system) 15 and above, or Android 7.0 and above, operating system Android 7.0 and above)
* Has daily internet access on smartphone
* Comfortable downloading and using smartphone apps
* Interested in working with an alcohol reduction coach via SMS text
* Willing to sign the Informed Consent Form (ICF)

Exclusion Criteria

* Currently using other support to reduce or quit alcohol, including apps, coaching, support groups, classes or quit programs
* Pregnant (self-reported)
* Self-reported past or present diagnosis of Alcohol Use Disorder (AUD)
* Self-reported past or present diagnosis of Substance Use Disorder
* Current use of the following medications: suboxone, methadone, or daily use of a benzodiazepine \[including Alprazolam (e.g., Xanax), lorazepam (e.g., Ativan), clonazepam (e.g., Klonopin), diazepam (e.g., Valium), and temazepam (e.g., Restoril)\]
* History of hospitalization or in-patient treatment due to alcohol use
* Using other alcohol reduction or abstinence apps, coaching, support groups, classes, or programs at study entry
* Failure to provide contact or collateral information, and/or failure to verify email address
* Participation in a previous study sponsored by Pivot Health Technologies, Inc. (formerly Carrot Inc.)
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pivot Health Technologies Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jennifer Marler, MD

VP of Clinical and Medical Affairs

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer Marler, MD

Role: PRINCIPAL_INVESTIGATOR

Pivot Health Technologies Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pivot Health Technologies, Inc.

San Carlos, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C-510

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimizing and Advancing SBIRT in Schools
NCT06206161 ENROLLING_BY_INVITATION NA